Pharmacologic treatment of persons with dizziness

Neurologic Clinics

Volumn 23, Issue 3, 2005, Pages 831-853

  Hain, Timothy C ^a   Yacovino, Dario ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b French Hospital ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMANTADINE; BACLOFEN; BETAHISTINE; CINNARIZINE; CLONAZEPAM; DIAZEPAM; DIMENHYDRINATE; FLUNARIZINE; GLYCOPYRRONIUM BROMIDE; GRANISETRON; LORAZEPAM; MECLOZINE; METOCLOPRAMIDE; NIMODIPINE; ONDANSETRON; PALONOSETRON; PIRACETAM; PROCHLORPERAZINE MALEATE; PROMETHAZINE; SCOPOLAMINE; THIETHYLPERAZINE MALEATE; TRIMETHOBENZAMIDE; VERAPAMIL;

ALLERGY; ANXIETY; CONFUSION; CONSTIPATION; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; EXTRAPYRAMIDAL SYNDROME; FEVER; FLUSHING; GINKGO BILOBA; HEADACHE; HUMAN; INSOMNIA; MENIERE DISEASE; NEUROCHEMISTRY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RASH; RESPIRATION DEPRESSION; RESTLESSNESS; REVIEW; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; TREMOR; VERTIGO; VOMITING; WEIGHT GAIN;

BENZODIAZEPINES; CHOLINERGIC ANTAGONISTS; DIZZINESS; HISTAMINE H1 ANTAGONISTS; HUMANS; VERTIGO;

EID: 22144452499     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2005.01.012     Document Type: Review

References (92)

1. S.B. Peppard Effect of drug therapy on compensation from vestibular injury Laryngoscope 96 1986 878 898
2. L. Petrosini, and M.E. Dell'Anna Vestibular compensation is affected by treatment with dopamine active agents Arch Ital Biol 131 1993 159 171
3. M.A. Serafin, A. Khateb, and C.D. Waele In vitro properties of medial vestibular neurones T. Shimazu Y. Shinoda Vestibular and brain stem control of head and body movement 1992 Karger Basel 111 121
4. J.J. Barton, A.G. Huaman, and J.A. Sharpe Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs Ann Neurol 35 1994 319 325
5. R.F. Spencer, S.F. Wang, and R. Baker The pathways and functions of Gaba in the oculomotor system Prog Brain Res 90 1992 307 331
6. J. Van Neerven, O. Pompeiano, and H. Collewijn Depression of the vestibulo-ocular and optokinetic responses by intrafloccular microinjection of Gaba-A and Gaba-B agonists in the rabbit Arch Ital Biol 127 1989 243 263
7. B. Cohen, D. Helwig, and T. Raphan Baclofen and velocity storage: a model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey J Physiol 393 1987 703 725
8. N. Takeda, M. Morita, and S. Hasegawa Neurochemical mechanisms of motion sickness Am J Otolaryngol 10 1989 351 359
9. C.D. Wood Antimotion sickness and antiemetic drugs Drugs 17 1979 471 479
10. I.S. Storper, J.B. Spitzer, and M. Scanlan Use of glycopyrrolate in the treatment of Meniere's disease Laryngoscope 108 10 1998 1442 1445
11. D.S. Zee The management of patients with vestibular disorders H.O. Barber J.A. Sharpe Vestibular disorders 1988 Yearbook Medical Publishing Chicago 254 274
12. C.M. Luetje, and J. Wooten Clinical manifestations of transdermal scopolamine addiction Ear Nose Throat J 75 1996 210 214
13. W.A. Ray, M.R. Griffin, and W. Schaffner Psychotropic drug use and the risk of hip fracture N Engl J Med 316 1987 363 369
14. W.A. Ray, R.L. Fought, and M.D. Decker Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers Am J Epidemiol 136 1992 873 883
15. J.A. Lee, L.A. Watson, and G. Boothby Calcium Antagonists in the prevention of motion sickness Aviat Space Environ Med 57 1986 45 48
16. J. Verspeelt, P. De Locht, and W.K. Amery Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine Eur J Clin Pharmacol 51 1996 15 22
17. L.F. Lassen, B.E. Hirsch, and D.B. Kamerer Use of nimodipine in the medical treatment of Meniere's disease: clinical Experience Am J Otol 17 1996 577 580
18. H.G. Markley Verapamil and migraine prophylaxis: mechanisms and efficacy Am J Med 90 5A 1991 48S 53S
19. I. Prigioni, S. Masetto, and G. Russo Calcium currents in solitary hair cells isolated from frog crista ampullaris J Vestib Res 2 1992 31 39
20. O. Rascol, M. Clanet, and J.L. Montastruc Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drug Fundam Clin Pharmacol 3 Suppl 1989 79s 87s
21. M.A. Mena, and M.J. Garcia de Yebenes Effects of calcium antagonists on the dopamine system Clin Neuropharmacol 18 1995 410 426
22. F.E. Micheli, M.M. Pardal, and R. Giannaula Movement disorders and depression due to flunarizine and cinnarizine Mov Disord 4 1989 139 146
23. A. Grontved, T. Brask, and J. Kambskard Ginger root against seasickness. A controlled trial on the open sea Acta Otolaryngol 105 1988 45 49
24. R.L. Kohl Failure of metoclopramide to control emesis or nausea due to stressful angular or linear Acceleration Aviat Space Environ Med 58 1987 125 131
25. J.A. Barone Domperidone: a peripherally acting dopamine2-receptor antagonist Ann Pharmacother 33 1999 429 440
26. H.L. Borison A misconception of motion sickness leads to false therapeutic expectations Aviat Space Environ Med 56 1985 66 68
27. H.L. Borison, R. Borison, and L.E. McCarthy Phylogenic and neurologic aspects of the vomiting process J Clin Pharmacol 21 8-9 Suppl 1981 23S 29S
28. J.R. Stott, G.R. Barnes, and R.J. Wright The Effect on motion sickness and oculomotor function of Gr 38032f, a 5-Ht3-receptor antagonist with anti-emetic properties Br J Clin Pharmacol 27 1989 147 157
29. M. Lacour, and O. Sterkers Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action CNS Drugs 15 2001 853 870
30. T. Brandt Vertigo: its multisensory syndromes 1999 Springer London
31. P.F. Smith, and C.L. Darlington Can vestibular compensation be enhanced by drug treatment? A review of recent evidence J Vestib Res 4 1994 169 179
32. P. Bernstein, B.F. McCabe, and J.H. Ryu The effect of diazepam on vestibular compensation Laryngoscope 84 1974 267 272
33. K. Ishikawa, and M. Igarashi Effect of diazepam on vestibular compensation in squirrel monkeys Arch Otorhinolaryngol 240 1984 49 54
34. J. Martin, D.P. Gilchrist, and P.F. Smith Early diazepam treatment following unilateral labyrinthectomy does not impair vestibular compensation of spontaneous nystagmus in guinea pig J Vestib Res 6 1996 135 139
35. F. Drago, L. Nardo, and L. Rampello Vestibular compensation in aged rats with unilateral labyrinthectomy treated with dopaminergic drugs Pharmacol Res 33 1996 135 140
36. E.A. Crisostomo, P.W. Duncan, and M. Propst Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients Ann Neurol 23 1988 94 97
37. D.P. Gilchrist, C.L. Darlington, and P.F. Smith Evidence that short ACTH fragments enhance vestibular compensation via direct action on the ipsilateral vestibular nucleus Neuroreport 7 1996 1489 1492
38. A.R. Johnston, J.R. Seckl, and M.B. Dutia Role of the flocculus in mediating vestibular nucleus neuron plasticity during vestibular compensation in the rat J Physiol 545 Pt 3 2002 903 911
39. V.C. Zingler, M. Strupp, and S. Krafczyk Does alcohol cancel static vestibular compensation? Ann Neurol 55 2004 144 145
40. E. Tolu, and O. Mameli Pharmacological improvement of vestibular plasticity. Effects of a Ca2 + -antagonist agent Pharmacol Res Commun 16 1984 1161 1173
41. W. Abeln, H. Bienhold, and H. Flohr Influence of cholinomimetics and cholinolytics on vestibular compensation Brain Res 222 1981 458 462
42. A.J. Sansom, C.L. Darlington, and P.F. Smith Intraventricular Injection of an N-methyl-D-aspartate antagonist disrupts vestibular compensation Neuropharmacology 29 1990 83 84
43. M.J. Ruckenstein, J.A. Rutka, and M. Hawke The treatment of Meniere's disease: torok revisited Laryngoscope 101 1991 211 218
44. N. Torok Old and new in Meniere disease Laryngoscope 87 1977 1870 1877
45. A.J. Fischer Histamine in the treatment of vertigo Acta Otolaryngol Suppl 479 1991 24 28
46. H. Kingma, M. Bonink, and A. Meulenbroeks Dose-dependent effect of betahistine on the vestibulo-ocular reflex: a double-blind, placebo controlled study in patients with paroxysmal vertigo Acta Otolaryngol 117 1997 641 646
47. L. Botta, E. Mira, and S. Valli Effects of betahistine on vestibular receptors of the frog Acta Otolaryngol 118 1998 519 523
48. J.K. Dziadziola, E.L. Laurikainen, and J.D. Rachel Betahistine increases vestibular blood flow Otolaryngol Head Neck Surg 120 1999 400 405
49. V. Colletti Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation Acta Otolaryngol Suppl 544 2000 27 33
50. M. Lacour, and B. Tighilet Vestibular compensation in the cat: the role of the histaminergic system Acta Otolaryngol Suppl 544 2000 15 18
51. B. Tighilet, J. Leonard, and M. Lacour Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat J Vestib Res 5 1995 53 66
52. M. Weiser, W. Strosser, and P. Klein Homeopathic vs conventional treatment of vertigo: a randomized double-blind controlled clinical study Arch Otolaryngol Head Neck Surg 124 1998 879 885
53. M. Lacour, L. Ez-Zaher, and J. Raymond Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of ginkgo biloba (Egb 761) Pharmacol Biochem Behav 40 1991 367 379
54. K. Maclennan, P.F. Smith, and C.L. Darlington Ginkgolide B accelerates vestibular compensation of spontaneous ocular nystagmus in guinea pig following unilateral labyrinthectomy Exp Neurol 131 1995 273 278
55. M. Schlatter, D.R. Kerr, and P.F. Smith Evidence that the ginkgo biloba extract, Egb 761, neither accelerates nor enhances the rapid compensation of the static symptoms of unilateral vestibular deafferentation in guinea pig J Vestib Res 9 1999 111 118
56. A. Cesarani, F. Meloni, and D. Alpini Ginkgo biloba (Egb 761) in the treatment of equilibrium disorders Adv Ther 15 1998 291 304
57. K. Kanda, Y. Watanabe, and H. Shojaku Effects of isosorbide in patients with Meniere's disease Acta Otolaryngol Suppl 504 1993 79 81
58. I. Nozawa, H. Nakayama, and K. Hashimoto Efficacy of long-term administration of isosorbide for Meniere's disease ORL J Otorhinolaryngol Relat Spec 57 1995 135 140
59. L. Incandela, M.R. Cesarone, and G. Belcaro Treatment of vascular inner ear disease with pentoxifylline: a 4-week, controlled, randomized trial Angiology 53 Suppl 1 2002 S19 S22
60. C.L. D'Hellencourt, L. Diaw, and P. Cornillet Differential regulation of Tnf alpha, Il-1 beta, Il-6, Il-8, Tnf beta, and Il-10 by pentoxifylline Int J Immunopharmacol 18 1996 739 748
61. M. Dieterich, A. Straube, and T. Brandt The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus J Neurol Neurosurg Psychiatry 54 1991 627 632
62. L. Andersson, M. Ulfendahl, and R. Tham A method for studying the effects of neurochemicals on long-term compensation in unilaterally labyrinthectomized rats J Neural Transplant Plast 6 1997 105 113
63. A.K. Magnusson, M. Ulfendahl, and R. Tham Early compensation of vestibulo-oculomotor symptoms after unilateral vestibular loss in rats is related to Gaba(b) receptor function Neuroscience 111 2002 625 634
64. B. Saniova, M. Drobny, and L. Kneslova The outcome of patients with severe head injuries treated with amantadine sulphate J Neural Transm 111 2004 511 514
65. N. Vibert, and P.P. Vidal In vitro effects of acetyl-Dl-leucine (tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig Eur J Neurosci 13 2001 735 748
66. C.D. Nicholson Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia Psychopharmacology (Berl) 101 1990 147 159
67. C.M. Fernandes, and J. Samuel The use of piracetam in vertigo S Afr Med J 68 1985 806 808
68. H. Hakkarainen, and L. Hakamies Piracetam in the treatment of post-concussional syndrome. A double-blind study Eur Neurol 17 1978 50 55
69. W.J. Oosterveld The efficacy of piracetam in vertigo. a double-blind study in patients with vertigo of central origin Arzneimittelforschung 30 1980 1947 1949
70. W. Chelen, M. Kabrisky, and C. Hatsell Use of phenytoin in the prevention of motion sickness Aviat Space Environ Med 61 1990 1022 1025
71. G.W. Knox, D. Woodard, and W. Chelen Phenytoin for motion sickness: clinical evaluation Laryngoscope 104 8 Pt 1 1994 935 939
72. M. Strupp, O. Schuler, and S. Krafczyk Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study Neurology 61 2003 165 170
73. J.M. Furman, and R.G. Jacob Psychiatric dizziness Neurology 48 5 1997 1161 1166
74. T. Brandt Benign paroxysmal positioning vertigo Adv Otorhinolaryngol 55 1999 169 194
75. S.D. Rauch, S.N. Merchant, and B.A. Thedinger Meniere's syndrome and endolymphatic hydrops. Double-blind temporal bone study Ann Otol Rhinol Laryngol 98 1989 873 883
76. P. Wladislavosky-Waserman, G.W. Facer, and B. Mokri Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, Mn, 1951-1980 Laryngoscope 94 1984 1098 1102
77. B. Mamikoglu, R.J. Wiet, and T. Hain Increased Cd4 + T Cells During acute attack of Meniere's disease Acta Otolaryngol 122 2002 857 860
78. J.J. Shea Jr. Classification of Meniere's disease Am J Otol 14 1993 224 229
79. J. Bergenius, and E. Borg Audio-vestibular findings in patients with vestibular neuritis Acta Otolaryngol 96 1983 389 395
80. M. Strupp, V.C. Zingler, and V. Arbusow Methylprednisolone, valacyclovir, or the combination for vestibular neuritis N Engl J Med 351 2004 354 361
81. T. Kitahara, K. Kondoh, and T. Morihana Steroid effects on vestibular compensation in human Neurol Res 25 2003 287 291
82. J.A.A. De Oliveria Audiovestibular toxicity of drugs 1989 CRC Press Boca Raton (Florida)
83. D.A. Drachman, and C.W. Hart An approach to the dizzy patient Neurology 22 1972 323 334
84. S. Juergens Alprazolam and diazepam: addiction potential J Subst Abuse Treat 8 1991 43 51
85. G.P. Rice, and G.C. Ebers Ondansetron for intractable vertigo complicating acute brainstem disorders Lancet 345 1995 1182 1183
86. R.W. Baloh, and A. Winder Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features Neurology 41 1991 429 433
87. L. Averbuch-Heller, R.J. Tusa, and L. Fuhry A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus Ann Neurol 41 1997 818 825
88. M.C. Lawden, A.M. Bronstein, and C. Kennard Repetitive paroxysmal nystagmus and vertigo Neurology 45 1995 276 280
89. L.E. Afzelius, N.G. Henriksson, and L. Wahlgren Vertigo and dizziness of functional origin Laryngoscope 91 4 1980 818 825
90. A.J. Campbell Drug treatment as a cause of falls in old age. A review of the offending agents Drugs Aging 1 1991 289 302
91. R.D. Herr, L. Zun, and J.J. Mathews A directed approach to the dizzy patient Ann Emerg Med 18 1989 664 672
92. P.D. Sloane Dizziness in primary care. results from the national ambulatory medical care survey J Fam Pract 29 1989 33 38